MRA Scientific Advisory Panel 2022-2023
Organizational Affiliations and Titles are included to identify individuals, however, all individuals listed serve in a personal capacity, and not as a representative of the organization to which they are employed.
Suzanne Topalian, MD — Chair
Professor, Surgery and Oncology
Director, Melanoma Program
Associate Director, Bloomberg-Kimmel Institute for Cancer Immunotherapy
Johns Hopkins Medicine
James Allison, PhD
Regental Professor & Chair, Department of Immunology
Olga Keith Wiess Distinguished University
Chair for Cancer Research
Director, Parker Institute for Cancer Immunotherapy
Executive Director, Immunotherapy Platform
Deputy Director, David H. Koch Center for Applied Research of Genitourinary Cancers
The University of Texas, MD Anderson Cancer Center
Boris Bastian, MD, PhD
Professor, Dermatology and Pathology
Gerson and Barbara Bass Bakar Distinguished
Professor, Cancer Research
University of California, San Francisco
Gina Fusaro, PhD
Vice President, Development Program Lead
Oncology Clinical Development
Bristol Myers Squibb
Gideon Bollag, PhD
Chief Executive Officer
Plexxikon, Inc.
Glenn Dranoff, MD
Global Head of Immuno-Oncology
Novartis Institutes for Biomedical Research
Gregory Friberg, MD
Vice President Medical Affairs ELMAC Region
Amgen
Levi Garraway, MD, PhD
Chief Medical Officer and Executive Vice President
Head of Global Product Development
Roche & Genentech
Allan C. Halpern, MD
Chief, Dermatology Service
Associate Chair, Promotions Advisory
Committee, Department of Medicine
Memorial Sloan Kettering Cancer Center
Nageatte Ibrahim, MD
Vice President, Oncology, Global Clinical Development
Merck
C. Daniela Robles-Espinoza PhD — Universidad Nacional Autónoma de México (Mexico)
Suzanne Topalian, MD – Johns Hopkins University, MRA Board of Directors, & Chair of MRA’s Scientific Advisory Panel
Howard Kaufman, MD
Head of Research and Development, Immuneering
Lecturer, Surgery, Harvard Medical School
Jeffrey Legos, PhD
Executive Vice President, Global Head of Oncology Development
Novartis Pharmaceuticals Corporation
Richard Marais, PhD, FMedSci
Director, Cancer Research
Professor, Molecular Oncology
UK Manchester Institute
Grant McArthur, PhD, FRACP
Fellow, Royal Australasian College of Physicians
Executive Director
Victorian Comprehensive Cancer Centre
Inaugural Lorenzo Galli Chair of Melanoma and Skin Cancers
University of Melbourne
Senior Principal Research Fellow
National Health & Medical Research Council
Head, Molecular Oncology Laboratory and Cancer Therapeutics Program
Senior Consultant Medical Oncologist, Cancer Medicine
Peter MacCallum Cancer Centre
Ira Mellman, PhD
Vice President, Cancer Immunology
Genentech
Caroline Robert, MD, PhD
Head, Dermatology Unit
Co-Director, Melanoma Research Unit
Professor, Dermatology
Institute Gustave Roussy
Neal Rosen, MD, PhD
Enid A. Haupt Chair in Medical Oncology
Memorial Sloan Kettering Cancer Center
David Solit, MD
Geoffrey Beene Chair
Director, Marie-Josée & Henry R. Kravis Center for Molecular Oncology
Memorial Sloan Kettering Cancer Center
Tara Withington, CAE
Vice President
Executive Director, Inc.
Executive Director Emeritus
Society for Immunotherapy of Cancer